Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Tuesday, March 19, 2024 · 697,025,645 Articles · 3+ Million Readers

America Pouchitis Global Market 2018: Key Players Astellas Pharma, Nestle, Sebela Pharmaceuticals, Probi and more

America Pouchitis 2018 Global Key Players - Astellas Pharma, Nestle, Sebela Pharmaceuticals, Probi Market Analysis and Forecast to 2023

PUNE, INDIA, May 31, 2018 /EINPresswire.com/ -- Introduction
Pouchitis is a nonspecific inflammatory condition in the ileal pouch reservoir. It is a common complication following proctocolectomy and ileal pouch-anal anastomosis. The condition exclusively occurs in patients with underlying Ulcerative Colitis (UC) and is rarely seen in patients with Familial Adenomatous Polyposis (FAP). Patients with UC or FAP opt for the Ileal Pouch-Anal Anastomosis (IPAA) surgery as a treatment and pouchitis appear as an outcome of this surgery in some cases.
On the basis of treatment, the Americas pouchitis treatment market is classified into antibiotics, probiotics, and others. The antibiotics segment held the largest market share in 2016.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3136559-america-pouchitis-treatment-market-research-report-forecast-to-2023

On the basis of end-user, the Americas pouchitis treatment market is segmented into hospitals and clinics, research institutes, and others. In 2016, hospitals and clinics accounted for the largest share in the Americas pouchitis treatment market.
Regionally, the market is segmented into North America and South America. North America held the largest market share in 2016 and is estimated to reach USD 15.06 million by 2023.

Key Players
The key players in the Americas IBS treatment market are Allergan Plc, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Valeant Pharmaceuticals, Abbott Laboratories, Synergy Pharmaceuticals, Inc., Ardelyx, Inc., Nestle, Sebela Pharmaceuticals, Probi, Alfasigma USA, Inc., and others.

Study objectives
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of market segments based on treatment, end-user, and region.
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the Americas pouchitis treatment market
• To provide a detailed analysis of the value chain and supply chain of the Americas pouchitis treatment market

Target Audience
• Pharmaceutical and Biotech Industries
• Potential Investors
• Medical Research Institutes
• Key Executive (CEO and COO) and Strategy Growth Managers
• Research Companies

Key Findings
• The major companies operating in the market are, Allergan Plc, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Valeant Pharmaceuticals, and Abbott Laboratories, among others
• Antibiotics segment registered USD 8.94 million market revenue in the year 2016 and is expected to grow during the forecast period
• Hospitals and clinics are the fastest growing segment, by end-user

Table of Content: Key Points
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Factor Analysis
5 Market Dynamics
6 Americas Pouchitis Treatment Market By Treatment
7 Americas Pouchitis Treatment Market By End User
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3136559-america-pouchitis-treatment-market-research-report-forecast-to-2023

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release